ASP5878
oral FGFR inhibitor Ph. I candidate for solid tumors opt. from previously disclosed lead Bioorg. Med. Chem. Astellas Pharma Inc.
Molecules of the Month - February 2022
oral FGFR inhibitor Ph. I candidate for solid tumors opt. from previously disclosed lead Bioorg. Med. Chem. Astellas Pharma Inc.
Molecules of the Month - February 2022